In May 2024, cancer specialists from around the world came together to attend the virtual 2nd China-Europe Anti-Cancer Summit, co-organised by the China Anti-Cancer Association (CACA) and the Latin-American & Caribbean Society of Medical Oncology (SLACOM).

 

Anti-cancer leaders from China and Europe took part in presentations and a panel discussion and exchanged ideas and perspectives on the following:

  • Development of holistic integrative management of cancer in China
  • Status and challenges of cancer prevention and control in Europe
  • A new anti-cancer paradigm by activation of thermogenic adipose tissue

 

 

Organised by CACA and SLACOM


 

Co-organised by eChinaHealth and COR2ED


China-Europe Anti-Cancer Summit 2024: Educational objectives

 

  • Share insights and perspectives on the management and treatment of cancer patients in China and Europe
  • Generate awareness of the latest innovations and progress in cancer research in China and Europe

Programme summary
  • clock Duration 101 MIN
  • clock Language(s) flag
Watch the video now
Share this programme
This educational programme is supported by an Independent Educational Grant from BeiGene.
Supporter Acknowledgement
This educational programme is supported by an Independent Educational Grant from BeiGene.
I agree that this educational programme:

Was valuable to me

1/4

Other programmes of interest

conference-update Conference update
Oncology 
Highlights from ESMO 2026

Experts join us at ESMO 2026 to share their insights on new data on GI, liver, lung, breast and GU cancers

Experts
Dr Elizabeth Smyth, Dr Yelena Janjigian, Assoc. Prof. Gerald Prager, Prof. Hong Jae Chon, Assoc. Prof. Lorenza Rimassa, Dr Tom Newsom-Davis, Dr Louise Lim, Dr Komal Jhaveri, Dr Roberto Iacovelli
Endorsed by
ICAN international cancer advocacy network Biomarker Collaborative Exon20group
MET crusaders
  • clock 3 MIN
  • calendar Oct 2026
  • Non-accredited Independent Medical Education

podcast Video podcast
Oncology 
Metastatic TNBC cannot wait

Optimising 1st line TROP2 ADC decisions in metastatic triple-negative breast cancer

Experts
Prof. Giuseppe Curigliano, Prof. Javier Cortés
  • download Downloadable
    Resources
  • clock 27 MIN
  • calendar Oct 2026
  • Non-accredited Independent Medical Education

Educational programme supported by an Independent Educational Grant from AstraZeneca.